Literature DB >> 14739871

Assessing the clinical significance of change scores recorded on subjective outcome measures.

Hugh Hurst1, Jennifer Bolton.   

Abstract

BACKGROUND: To date, clinical trials have relied almost exclusively on the statistical significance of changes in scores from outcome measures in interpreting the effectiveness of treatment interventions. It is becoming increasingly important, however, to determine the clinical rather than statistical significance of these change scores.
OBJECTIVE: To determine cutoff values for change scores that distinguish patients who have clinically improved from those who have not.
METHOD: Data were obtained from 165 back and 100 neck patients undergoing chiropractic treatment. Patients completed the Bournemouth Questionnaire (BQ) before treatment and the BQ and Patient's Global Impression of Change (PGIC) scale after treatment. Three statistical methods were applied to individual change scores on the BQ. These were (1) the Reliable Change Index (RCI); (2) the effect size (ES); and (3) the raw and percentage change scores. The PGIC scale was used as the "gold standard" of clinically significant change.
RESULTS: The RCI, using the cutoff value of >1.96, appropriately identified clinical improvement in back patients but not in neck patients. An individual ES of approximately 0.5 had the highest sensitivity and specificity in distinguishing back and neck patients who had undergone clinically significant improvement from those who had not. In terms of raw score changes, percentage BQ change scores [(raw change score/baseline score) x 100] of 47% and 34% were identified as having the highest sensitivity and specificity in distinguishing clinically significant improvement from nonimprovement in back and neck patients, respectively.
CONCLUSION: This study provides a methodological framework for identifying clinically significant change in patients. This approach has important implications in providing clinically relevant information about the effect of a treatment intervention in an individual patient.

Entities:  

Mesh:

Year:  2004        PMID: 14739871     DOI: 10.1016/j.jmpt.2003.11.003

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  172 in total

1.  Pain reduction of topical sevoflurane vs intravenous opioids in pressure ulcers.

Authors:  F Dámaso Fernández-Ginés; Manuel Cortiñas-Sáenz; Desirée Agudo-Ponce; Ana Navajas-Gómez de Aranda; José A Morales-Molina; Carmen Fernández-Sánchez; Francisco Sierra-García; Héctor Mateo-Carrasco
Journal:  Int Wound J       Date:  2019-11-25       Impact factor: 3.315

2.  Measuring clinically meaningful change following mental health treatment.

Authors:  Susan V Eisen; Gayatri Ranganathan; Pradipta Seal; Avron Spiro
Journal:  J Behav Health Serv Res       Date:  2007-05-30       Impact factor: 1.505

3.  Validation of the French version of the Bournemouth Questionnaire.

Authors:  Johanne Martel; Claude Dugas; D Lafond; M Descarreaux
Journal:  J Can Chiropr Assoc       Date:  2009

4.  Impact of an Electronic Pain and Opioid Risk Assessment Program: Are There Improvements in Patient Encounters and Clinic Notes?

Authors:  Stephen F Butler; Kevin L Zacharoff; Sadaf Charity; Ryan A Black; Emma Chung; Antje Barreveld; Molly S Clark; Robert N Jamison
Journal:  Pain Med       Date:  2016-04-20       Impact factor: 3.750

5.  Long-term efficacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain.

Authors:  Mario Dauri; Marzia Lazzari; Manuela Casali; Giuseppe Tufaro; Elisabetta Sabato; Alessandro Fabrizio Sabato
Journal:  Clin Drug Investig       Date:  2014-05       Impact factor: 2.859

Review 6.  Core domain and outcome measurement sets for shoulder pain trials are needed: systematic review of physical therapy trials.

Authors:  Matthew J Page; Joanne E McKenzie; Sally E Green; Dorcas E Beaton; Nitin B Jain; Mario Lenza; Arianne P Verhagen; Stephen Surace; Jessica Deitch; Rachelle Buchbinder
Journal:  J Clin Epidemiol       Date:  2015-06-16       Impact factor: 6.437

Review 7.  Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Authors:  Barbara S Koppel; John C M Brust; Terry Fife; Jeff Bronstein; Sarah Youssof; Gary Gronseth; David Gloss
Journal:  Neurology       Date:  2014-04-29       Impact factor: 9.910

8.  Development of a clinical prediction rule to identify patients with neck pain likely to benefit from cervical traction and exercise.

Authors:  Nicole H Raney; Evan J Petersen; Tracy A Smith; James E Cowan; Daniel G Rendeiro; Gail D Deyle; John D Childs
Journal:  Eur Spine J       Date:  2009-01-14       Impact factor: 3.134

9.  Preliminary study into the components of the fear-avoidance model of LBP: change after an initial chiropractic visit and influence on outcome.

Authors:  Jonathan R Field; Dave Newell; Peter W McCarthy
Journal:  Chiropr Osteopat       Date:  2010-07-30

10.  Relative effectiveness and adverse effects of cervical manipulation, mobilisation and the activator instrument in patients with sub-acute non-specific neck pain: results from a stopped randomised trial.

Authors:  Hugh Gemmell; Peter Miller
Journal:  Chiropr Osteopat       Date:  2010-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.